Immuneering

IMRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$298.255 M

$4.61 +3.83%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$56.0M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#235InflaRxIFRX$306.5M
#236Upstream BioUPB$300.7M
#237ImmuneeringIMRX$298.3M
#238Fulcrum TherapeuticsFULC$293.0M
#239Zentalis PharmaceuticalsZNTL$291.6M

What if Immuneering were worth as much as…

Open the what-if tool →

Gold $30.2T

$467,313.51

Per share 101,370× higher

Bitcoin $1.74T

$26,920.02

Per share 5,839× higher

Nvidia $5.52T

$85,254.85

Per share 18,493× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Immuneering are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.